TRADE NEWS: Agilent Technologies Launches RapidFire 365 High-Throughput Mass Spectrometry System

  TRADE NEWS: Agilent Technologies Launches RapidFire 365 High-Throughput Mass
  Spectrometry System

Product Provides Walkaway Mass Spectrometric Analysis for Researchers Working
         on Drug Discovery, Clinical Research and Forensic Toxicology

Business Wire

SANTA CLARA, Calif. -- June 10, 2013

Agilent Technologies Inc. (NYSE: A) today launched the RapidFire 365
High-throughput Mass Spectrometry System. The system offers increased plate
capacity, full integration with Agilent’s BenchBot Robot automation technology
and improved productivity for researchers working on drug discovery, clinical
research and forensic toxicology.

Fully compatible with Agilent’s entire line of mass spectrometers, the
RapidFire 365 high-throughput mass spectrometry system offers numerous
advancements:

  *The system runs unattended for up to 60 hours, facilitating more than
    20,000 injections and enabling over-the-weekend runs.
  *It analyzes multiple assays in a single, unattended run.
  *It automates method development for novel analytes.
  *It provides intuitive data review and visualization, using RapidFire
    Integrator 2.0 software.

The RapidFire 365 can also identify active compounds against challenging
targets, confirm the activity of those compounds, and assess absorption,
distribution, metabolism, elimination and physiochemical properties of those
compounds.

“Agilent is excited to offer a single end-to-end platform for fast,
cost-effective, automated, walkaway mass spectrometric analysis,” said Can
(Jon) Ozbal, Ph.D., director of RapidFire operations. “The RapidFire 365
brings us closer to our vision of creating a label-free MS-based workflow that
rivals the simplicity of a plate reader while avoiding the pitfalls of optical
assays.”

The new RapidFire system offers a strong application focus in HTS, including
epigenetics and fragment-based drug discovery, as well as generating
equivalent data to HPLC-MS in a fraction of the time and cost for a wide range
of clinical research and forensic toxicology applications.

Agilent’s RapidFire solutions—front-end systems based on solid-phase
extraction—enable detection of native compounds by mass spectrometry.
Requiring no labels or surrogates, RapidFire technology allows users to screen
intractable or challenging targets that are not amenable to fluorescence or
luminescence. Sample throughput is 10 times faster than conventional MS
screening methods.

For more information
http://www.chem.agilent.com/en-US/products-services/Instruments-Systems/Mass-Spectrometry/RapidFire-365/Pages/default.aspx

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news
is available at www.agilent.com/go/news.

Contact:

Agilent Technologies Inc.
Eric Endicott, +1 408-553-2005
eric_endicott@agilent.com
 
Press spacebar to pause and continue. Press esc to stop.